2 Amendments of Tokia SAÏFI related to 2008/2135(INI)
Amendment 67 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Acknowledges that India's standards regime is still evolving; calls on the Bureau of Indian Standards and the Central Drugs Standard Control Organisation (CDSCO) to raise its standards in line with international standards and to increase transparency by improving its testing and certification procedures; calls on the Commission to provide adequate support to strengthen capacity and qualified human resources within Indian regulatory bodies;
Amendment 124 #
Motion for a resolution
Paragraph 28
Paragraph 28
28. Regrets the Indian Patent Amendment Act does not contain any provisions on data exclusivityprotection; notes that lack of data protection and exclusivity are of major concern for EU pharmaceutical companies in Indiais of major concern for EU pharmaceutical companies in India; calls on the Commission to hold discussions on the subject in order to respond to this concern, whilst asking European pharmaceutical undertakings to develop public-private partnerships to respond to public health needs; welcomes India's commitment to increase the share of its public spending for health and encourages this trend with a view to ensuring adequate access to effective healthcare services, particularly in rural areas;